Date published: 2026-4-12

1-800-457-3801

SCBT Portrait Logo
Seach Input

Tryptase Inhibitors

Tryptase inhibitors are a class of chemical compounds that have been designed to selectively bind to and inhibit the activity of tryptase, a type of protease enzyme. Tryptases are serine proteases, meaning they have a serine residue at their active site that is crucial for their catalytic mechanism. They are typically stored in and released from the secretory granules of mast cells and are known to cleave peptide bonds in proteins. Tryptase plays a role in various biological processes due to its proteolytic activity. Because of the specific nature of their catalysis, which involves the cleavage of peptide bonds adjacent to arginine or lysine residues, tryptases have a substrate preference that is somewhat distinct within the serine protease family. The design of tryptase inhibitors, therefore, focuses on the creation of molecules that can interact with this active site and block its function, preventing the enzyme from performing its natural catalytic activity. The development of tryptase inhibitors begins with a thorough understanding of the enzyme's structure. The active site of tryptase is a key focus, as it provides the region where the enzyme binds to its substrates and carries out the hydrolysis of peptide bonds. Researchers utilize a variety of methods to elucidate the structure of tryptases, including X-ray crystallography and computational modeling. By understanding the topography and electronic characteristics of the active site, scientists can design inhibitors that are complementary in shape and charge, allowing them to bind tightly to the enzyme. These inhibitors often mimic the transition state or part of the substrate molecule that the enzyme interacts with during the catalytic process. By doing so, they can effectively occupy the active site and prevent access to the natural substrate. Inhibitors may be designed to form reversible or irreversible bonds with the enzyme, with reversible inhibitors typically forming non-covalent interactions and irreversible inhibitors often forming a covalent bond with the serine residue at the active site.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

TLCK hydrochloride

4238-41-9sc-201296
200 mg
$150.00
2
(1)

TLCK hydrochloride is a potent inhibitor of tryptase, characterized by its unique ability to form stable complexes with the enzyme's active site. The compound's structural features facilitate specific interactions, leading to a significant alteration in the enzyme's catalytic efficiency. Its kinetic profile reveals a competitive inhibition mechanism, where the presence of TLCK hydrochloride effectively modulates tryptase activity, providing a deeper understanding of proteolytic regulation in biological systems.

Benzamidine Hydrochloride, Anhydrous

1670-14-0sc-202973
sc-202973A
sc-202973B
sc-202973C
sc-202973D
sc-202973E
5 g
25 g
100 g
250 g
1 kg
5 kg
$44.00
$148.00
$260.00
$364.00
$832.00
$3329.00
11
(1)

Benzamidine Hydrochloride, Anhydrous, is a selective inhibitor of tryptase, distinguished by its ability to engage in hydrogen bonding and electrostatic interactions with the enzyme's active site. This compound exhibits a unique affinity for the serine residue, influencing the enzyme's conformational dynamics. Its reaction kinetics suggest a non-competitive inhibition pathway, allowing for nuanced modulation of proteolytic activity, thereby enhancing insights into enzymatic regulation mechanisms.

Cromolyn disodium salt

15826-37-6sc-207459
sc-207459A
sc-207459B
sc-207459C
sc-207459D
sc-207459E
sc-207459F
1 g
5 g
25 g
50 g
100 g
500 g
1 kg
$50.00
$174.00
$624.00
$1040.00
$1873.00
$2913.00
$3537.00
(1)

Stabilizes mast cells, potentially reducing tryptase release upon activation.

uPA Inhibitor Inhibitor

149732-36-5sc-356184
5 mg
$317.00
1
(0)

uPA Inhibitor functions as a potent modulator of tryptase activity, characterized by its specific binding interactions that stabilize the enzyme's inactive form. This compound exhibits unique allosteric effects, altering the enzyme's conformation and impacting substrate accessibility. Its kinetic profile reveals a mixed inhibition mechanism, providing insights into the intricate balance of protease regulation. The inhibitor's structural features facilitate selective targeting, enhancing understanding of proteolytic pathways.

Montelukast Sodium

151767-02-1sc-202231
sc-202231A
sc-202231B
10 mg
25 mg
250 mg
$51.00
$85.00
$161.00
5
(1)

A leukotriene receptor antagonist that may reduce mast cell activation and tryptase expression.

Theophylline

58-55-9sc-202835
sc-202835A
sc-202835B
5 g
25 g
100 g
$20.00
$32.00
$85.00
6
(0)

Phosphodiesterase inhibitor, could reduce mast cell activation by increasing intracellular cAMP levels, thereby reducing tryptase expression.

Apigenin

520-36-5sc-3529
sc-3529A
sc-3529B
sc-3529C
sc-3529D
sc-3529E
sc-3529F
5 mg
100 mg
1 g
5 g
25 g
100 g
1 kg
$33.00
$214.00
$734.00
$1151.00
$2348.00
$3127.00
$5208.00
22
(1)

A flavonoid that may inhibit protein kinase C, which is involved in the signal transduction of mast cell activation.

Quercetin

117-39-5sc-206089
sc-206089A
sc-206089E
sc-206089C
sc-206089D
sc-206089B
100 mg
500 mg
100 g
250 g
1 kg
25 g
$11.00
$17.00
$110.00
$250.00
$936.00
$50.00
33
(2)

Another flavonoid that has been shown to stabilize mast cells and potentially reduce tryptase release.

Zileuton

111406-87-2sc-204417
sc-204417A
sc-204417B
sc-204417C
10 mg
50 mg
1 g
75 g
$84.00
$307.00
$369.00
$1254.00
8
(1)

A 5-lipoxygenase inhibitor that may lead to reduced leukotriene production, thereby decreasing mast cell activation and tryptase expression.

Marimastat

154039-60-8sc-202223
sc-202223A
sc-202223B
sc-202223C
sc-202223E
5 mg
10 mg
25 mg
50 mg
400 mg
$168.00
$218.00
$404.00
$629.00
$4900.00
19
(1)

A broad-spectrum matrix metalloprotease inhibitor that could indirectly affect extracellular matrix interactions with mast cells and tryptase release.